ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed
Daniel Wicklein
Matched on ORCID iD 0000-0003-0007-8708; OpenAlex author ID A5030831269. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2013: 1 paper · 2014: 3 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 5
- Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. Last author DOI 10.1186/s13046-021-01946-2↗
- L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Co-author DOI 10.1016/j.molonc.2014.03.001↗
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. First author DOI 10.1371/journal.pone.0113023↗
- Serum EpCAM expression in pancreatic cancer. Co-author PMID 25202052↗
- Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice. First author DOI 10.1136/gutjnl-2011-300629↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Udo Schumacher · 5 shared papers, 2013–2021 · strength 0.26
- Paper Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. DOI 10.1186/s13046-021-01946-2↗
- Paper Serum EpCAM expression in pancreatic cancer. PMID 25202052↗
- Paper Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. DOI 10.1371/journal.pone.0113023↗
- Florian Gebauer · 4 shared papers, 2013–2021 · strength 0.23
- Paper Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. DOI 10.1186/s13046-021-01946-2↗
- Paper Serum EpCAM expression in pancreatic cancer. PMID 25202052↗
- Paper Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. DOI 10.1371/journal.pone.0113023↗
- Jakob Robert Izbicki · 4 shared papers, 2013–2021 · strength 0.23
- Paper Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. DOI 10.1186/s13046-021-01946-2↗
- Paper Serum EpCAM expression in pancreatic cancer. PMID 25202052↗
- Paper Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. DOI 10.1371/journal.pone.0113023↗
- Michael Tachezy · 3 shared papers, 2014–2021 · strength 0.20
- Paper Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. DOI 10.1186/s13046-021-01946-2↗
- Paper Serum EpCAM expression in pancreatic cancer. PMID 25202052↗
- Paper Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. DOI 10.1371/journal.pone.0113023↗
- Maximilian Bockhorn · 3 shared papers, 2013–2014 · strength 0.12
- Paper Serum EpCAM expression in pancreatic cancer. PMID 25202052↗
- Paper Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. DOI 10.1371/journal.pone.0113023↗
- Paper Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in … DOI 10.1136/gutjnl-2011-300629↗
- Achim Michael Aigner · 1 shared paper, 2021 · strength 0.11
- Marius Kemper · 1 shared paper, 2021 · strength 0.11
- Yogesh Kumar Vashist · 1 shared paper, 2014 · strength 0.04
- Daniela Wesch · 1 shared paper, 2014 · strength 0.04
- H. Schäfer · 1 shared paper, 2014 · strength 0.04
- Christoph Röcken · 1 shared paper, 2014 · strength 0.04
- Lisa Goebel · 1 shared paper, 2014 · strength 0.04
- Evelin Grage‐Griebenow · 1 shared paper, 2014 · strength 0.04
- Susanne Sebens · 1 shared paper, 2014 · strength 0.04
- Michael Fabian Nentwich · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.